Topics

Lumos Diagnostics Company Profile

00:29 EST 27th February 2020 | BioPortfolio

Lumos Diagnostics provides rapid, cost effective, and complete point-of-care (POC) diagnostic test solutions that utilize proprietary digital reader platforms to help healthcare professionals more accurately diagnose and manage diseases and medical conditions. Lumos provides assay development and manufacturing services for customized POC tests as well as directly develops, manufactures, and will commercialize a suite of Lumos-branded POC tests. Conditions targeted by Lumos tests include infectious and inflammatory diseases with unmet diagnostic needs, including fever, biological threats, and infectious disease, resulting in less unnecessary treatments with associated adverse events, reduced spread of disease, and more effective antibiotic stewardship initiatives.


News Articles [423 Associated News Articles listed on BioPortfolio]

Lumos Diagnostics Raises $15M to Expand Point of Care Diagnostic Solutions Internationally

– Lumos Diagnostics raises $15M in Series A funding to support the international expansion of its point of care diagnostic solutions. – Lumos provides assay development and manufacturing s...

Lumos Diagnostics secures $15m in series A funding from Planet Innovation

Lumos Diagnostics announced the closing of U.S. $15 million in Series A funding from Planet Innovation, an Australia-based healthtech innovation and commercialization company. This funding will suppor...

Lumos secures $15M in Series A financing

Lumos Diagnostics received $15 million from Planet Innovation in a Series A financing round.  -More- 

NewLink Genetics and Lumos Pharma to Form Biopharma Company

The agreement is expected to close in Q1 2020. NewLink Genetics will change its name to Lumos Pharma and its ticker will becomeLUMO. The post NewLink Genetics and Lumos Pharma to Form Biopharma Compan...

NewLink Genetics, Lumos Pharma reverse merge

NewLink Genetics Corp. is merging with Lumos Pharma Inc. in a stock swap creating a company that will focus on therapies for rare diseases.

 Lumos Diagnostics Secures $15M in Series A Funding from Planet Innovation

Lumos Diagnostics announced the closing of U.S. $15 million in Series A funding from Planet Innovation, an Australia-based healthtech innovation and commercialization company. This funding will suppo...

NewLink Genetics and Lumos Pharma Enter into Merger Agreement to Form Company Focused on Developing Rare Disease Drugs

AUSTIN, Texas and AMES, Iowa, Sept. 30, 2019 (GLOBE NEWSWIRE) — NewLink Genetics Corporation (NASDAQ:NLNK) and Lumos Pharma, Inc., a private clinical stage biopharmaceutical company focused on d...

FebriDx® Wins Biomarkers Award at 2019 UK Diagnostics Summit

Lumos Diagnostics, a point-of-care (POC) diagnostic test developer, manufacturer and marketer received the Biomarkers Award at the recent 2019 UK Diagnostics Summit in Manchester, England for FebriDx...

PubMed Articles [208 Associated PubMed Articles listed on BioPortfolio]

Diagnostics in space: will zero gravity add weight to new advances?

Possibilities of modern x-ray examination methods for diagnostics of hidden dental caries of approximal localization.

Introduction: In case of hidden carious cavities development on the approximal teeth surfaces, the clinical diagnostics of this process is difficult. Then, the diagnostics of carious lesion is not pos...

Optimization of the preanalytical phase of laboratory diagnostics in intensive care and disaster medicine.

The use of point-of-care diagnostics can prevent a number of complications and leading to improved health outcomes for patients in critical condition. Research have shown that elongation of the preana...

Bloodstream infections - Standard and progress in pathogen diagnostics.

Bloodstream infection (BSI) is a major public health burden worldwide, with high mortality. Patient outcome is critically influenced by delayed therapy, and fast and accurate pathogen diagnostics deci...

Diagnostic Challenges in Newborns and Infants with Coagulation Disorders.

Laboratory diagnostics in children and adolescents, especially in newborns and very small children, differ considerably compared with laboratory diagnostics in adults. This applies to all individual s...

Clinical Trials [309 Associated Clinical Trials listed on BioPortfolio]

Reliability and Validity of Online Cognitive Assessments

The purpose of this study is to evaluate the concurrent validity (correlation coefficient of scores at 1 time point) between the Brain Performance Test (BPT, Lumos Labs, Inc.) and a valida...

Differential Diagnostics of Etiology of Acute Infections

Method for diagnostics of the origin of infections (bacterial vs viral) based on the identification of activation markers of blood neutrophils and monocytes will be developed.

Application of Clinical Metagenomics in the Diagnosis of Ascites

Infection of the ascitic fluid is a serious complication associated with high morbidity and mortality. This fluid is often colonized with bacteria that can cause infection of the peritoneu...

Diagnostics and Pharmacotherapy for Severe Forms of TB (DMID 15-0100)

Major Research Aim: To study novel molecular diagnostics and the pharmacokinetic variability among a spectrum of TB disease states, including severe forms of TB like disseminated TB, TB me...

Bedside vs. Standard Microbiological Blood Culture Diagnostics - BEMIDIA Study

With a completely bedside blood culture diagnostics system (BACTEC blood culture system in combination with the Accelerate ID/AST System) it is possible to optimize the initial antimicrobi...

Companies [996 Associated Companies listed on BioPortfolio]

Lumos Diagnostics

Lumos Diagnostics provides rapid, cost effective, and complete point-of-care (POC) diagnostic test solutions that utilize proprietary digital reader platforms to help healthcare p...

Lumos Networks Corp.

Lumos Networks is a fiber-based service provider in the Mid-Atlantic region serving carrier, business and residential customers over a dense fiber network offering data, voice and...

Lumos Labs, Inc.

Lumos Labs is the cognitive neuroscience research and development company behind Lumosity.com, the #1 destination for healthy online brain training with over 7 million members. Th...

Lumos Pharma, Inc.

Lumos Pharma, Inc. is a clinical stage biopharmaceutical company focused on development and commercialization of therapeutics for rare and neglected diseases. Lumos Pharma was fou...

Sekisui Diagnostics

A Sekisui Chemical company since 2011, Sekisui Diagnostics is a leading supplier of high quality products to diagnostic manufacturers, clinical laboratories and physician offices ...

More Information about "Lumos Diagnostics" on BioPortfolio

We have published hundreds of Lumos Diagnostics news stories on BioPortfolio along with dozens of Lumos Diagnostics Clinical Trials and PubMed Articles about Lumos Diagnostics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Lumos Diagnostics Companies in our database. You can also find out about relevant Lumos Diagnostics Drugs and Medications on this site too.

Quick Search

Relevant Topics

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...

Assays
An assay is an analytic procedure for qualitatively assessing or quantitatively measuring the presence or amount or the functional activity of a target entity.  This can be a drug or biochemical substance or a cell in an organism or organic sample. ...


Corporate Database Quicklinks



Searches Linking to this Company Record